OSHA SearchOSHA records by employer

Abeona Therapeutics: OSHA inspections and violations

Cleveland, Ohio · Pharmaceutical Preparation Manufacturing · NAICS 325412

2inspections
8citation items
$18,053current penalties
May 2, 2022last inspection

Since 2022, OSHA inspectors have visited Abeona Therapeutics in Ohio 2 times.

The most recent inspection opened on May 2, 2022 on a referral, in Cleveland.

In all, OSHA issued 8 citation items: 3 serious and 5 other-than-serious.

The proposed penalties came to $30,456; today they stand at $18,053, 41% less.

The rule cited most here is 1910.1030 (bloodborne pathogens), 3 times.

Among manufacturing employers, the typical cited inspection since 2015 ends with a $4,500 penalty. Abeona Therapeutics averages $18,053 across 1 cited inspection.

Abeona Therapeutics also files yearly injury logs with OSHA, summarized below.

Abeona Therapeutics: OSHA citation items per year, 2022 to 2022
Citation items per year, by inspection date.

Ohio · latest 90 days of OSHA records

260employers cited

Get notified the morning OSHA posts each new citation in Ohio: the employer, the site address, the rules broken and the penalty.

See who gets cited next

Latest cited in Ohio

Checking a subcontractor, a client or your own company? Watch Abeona Therapeutics and get notified the morning OSHA posts a new citation for it.

Watch this company

Inspection history

Inspection 345930218 OPENED MAY 2, 2022Closed

Referral · Records only · Health · 59 employees at the site · Closed Jul 14, 2022

6555 Carnegie Ave, Cleveland, OH 44103 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

No citations from this inspection.

Inspection 345927628 OPENED APR 29, 2022Closed

Complaint · Partial · Health · 59 employees at the site · Closed Nov 3, 2022

6555 Carnegie Ave, Cleveland, OH 44103 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

Citation and ruleTypeProposedCurrentIssuedStatus
Citation 1, item 1a
29 CFR 1910.132(a) · Personal protective equipment, general requirements
Serious$7,252$7,252Aug 9, 2022Final
Citation 1, item 1b
29 CFR 1910.132(d)(2) · Personal protective equipment, general requirements
Serious$0$0Aug 9, 2022Final
Citation 1, item 2
29 CFR 1910.151(c) · First aid and eyewash
Serious$5,801$5,801Aug 9, 2022Final
Citation 1, item 3a
29 CFR 1910.1030(c)(1)(i) · Bloodborne pathogens
Other-than-serious$10,151$3,000Aug 9, 2022Final
Citation 1, item 3b
29 CFR 1910.1030(f)(2)(i) · Bloodborne pathogens
Other-than-serious$0$0Aug 9, 2022Final
Citation 1, item 4a
29 CFR 1910.1450(e)(1) · Occupational exposure to hazardous chemicals in laboratories
Other-than-serious$7,252$2,000Aug 9, 2022Final
Citation 1, item 4b
29 CFR 1910.1450(f)(1) · Occupational exposure to hazardous chemicals in laboratories
Other-than-serious$0$0Aug 9, 2022Final
Citation 2, item 1
29 CFR 1910.1030(g)(2)(vii)(n) · Bloodborne pathogens
Other-than-serious$0$0Aug 9, 2022Final

Injury and illness logs

From the Form 300A summaries employers file with OSHA each year. Rate = recordable cases per 100 full-time workers.

In 2023, the Cleveland site logged 2 recordable injuries or illnesses among about 61 workers: 2.6 per 100 full-time workers, against a median of 1.1 for its industry.

Site and yearWorkersCasesDays-away casesRateIndustry median
Abeona Therapeutics Cleveland
Cleveland · 2023
61 202.61.1

The rules behind these citations

Current text from the Code of Federal Regulations. Some citations were issued under older wording.

29 CFR 1910.1030 · Bloodborne pathogens

29 CFR 1910.1030(c)(1)(i)

(c) Exposure control—(1) Exposure Control Plan. (i) Each employer having an employee(s) with occupational exposure as defined by paragraph (b) of this section shall establish a written Exposure Control Plan designed to eliminate or minimize employee exposure.

29 CFR 1910.1030(f)(2)(i)

(2) Hepatitis B Vaccination. (i) Hepatitis B vaccination shall be made available after the employee has received the training required in paragraph (g)(2)(vii)(I) and within 10 working days of initial assignment to all employees who have occupational exposure unless the employee has previously received the complete hepatitis B vaccination series, antibody testing has revealed that the employee is immune, or the vaccine is contraindicated for medical reasons.

29 CFR 1910.1030(g)(2)(vii)(n)

(N) An opportunity for interactive questions and answers with the person conducting the training session.

29 CFR 1910.132 · Personal protective equipment, general requirements

29 CFR 1910.1450 · Occupational exposure to hazardous chemicals in laboratories

29 CFR 1910.151 · First aid and eyewash

Other pharmaceutical preparation manufacturing employers in Ohio

Alert subscribers get notified of each newly cited employer in Ohio the morning it is posted. See the alert plans.

Source: U.S. Department of Labor, OSHA enforcement data. A citation is OSHA's allegation; employers can contest it, and the status column shows where each item stands. Something wrong on this page? Tell us.